$148 Million is the total value of Michelson Medical Research Foundation, Inc.'s 27 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HYG | ISHARES TRiboxx hi yd etf | $18,808,184 | -1.8% | 255,130 | 0.0% | 12.70% | -6.8% | |
BKLN | INVESCO EXCH TRADED FD TR IIsr ln etf | $12,606,804 | -0.2% | 600,610 | 0.0% | 8.51% | -5.3% | |
BSV | VANGUARD BD INDEX FDSshort trm bond | $12,391,399 | -0.5% | 164,845 | 0.0% | 8.37% | -5.6% | |
VWO | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $9,278,262 | -3.6% | 236,630 | 0.0% | 6.26% | -8.5% | |
IVE | ISHARES TRs&p 500 val etf | $7,985,065 | -4.6% | 51,905 | 0.0% | 5.39% | -9.4% | |
IVV | ISHARES TRcore s&p500 etf | $7,725,016 | -3.7% | 17,989 | 0.0% | 5.22% | -8.6% | |
AVB | AVALONBAY CMNTYS INC | $7,639,854 | -9.3% | 44,485 | 0.0% | 5.16% | -13.9% | |
HDV | ISHARES TRcore high dv etf | $7,242,704 | -1.9% | 73,240 | 0.0% | 4.89% | -6.9% | |
IBB | ISHARES TRishares biotech | $5,306,775 | -3.7% | 43,395 | 0.0% | 3.58% | -8.6% | |
PLD | PROLOGIS INC. | $4,758,265 | -8.5% | 42,405 | 0.0% | 3.21% | -13.2% | |
ARE | ALEXANDRIA REAL ESTATE EQ IN | $3,726,723 | -11.8% | 37,230 | 0.0% | 2.52% | -16.3% | |
CRC | CALIFORNIA RES CORP | $3,273,785 | +23.7% | 58,450 | 0.0% | 2.21% | +17.4% | |
PFF | ISHARES TRpfd and incm sec | $2,471,396 | -2.5% | 81,970 | 0.0% | 1.67% | -7.5% | |
TALO | TALOS ENERGY INC | $2,297,983 | +18.5% | 139,780 | 0.0% | 1.55% | +12.5% | |
XBI | SPDR SER TRs&p biotech | $2,285,526 | -12.2% | 31,300 | 0.0% | 1.54% | -16.7% | |
CRESCENT ENERGY COMPANY | $1,973,938 | +21.3% | 156,166 | 0.0% | 1.33% | +15.1% | ||
BXP | BOSTON PROPERTIES INC | $1,292,798 | +3.3% | 21,735 | 0.0% | 0.87% | -2.0% | |
NML | NEUBERGER BERMAN ENERGY INFR | $797,199 | 0.0% | 115,872 | 0.0% | 0.54% | -5.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 4 | Q3 2023 | 15.1% |
VANGUARD TAX-MANAGED FDS | 4 | Q3 2023 | 10.8% |
VANGUARD BD INDEX FDS | 4 | Q3 2023 | 9.9% |
INVESCO EXCH TRADED FD TR II | 4 | Q3 2023 | 9.8% |
VANGUARD INTL EQUITY INDEX F | 4 | Q3 2023 | 7.5% |
ISHARES TR | 4 | Q3 2023 | 8.7% |
ISHARES TR | 4 | Q3 2023 | 8.4% |
ISHARES TR | 4 | Q3 2023 | 8.9% |
AVALONBAY CMNTYS INC | 4 | Q3 2023 | 6.0% |
ISHARES TR | 4 | Q3 2023 | 4.4% |
View Michelson Medical Research Foundation, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
View Michelson Medical Research Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.